Loading...
XLONAVG
Market cap154mUSD
Jan 03, Last price  
375.00GBP
1D
0.00%
1Q
-9.09%
Jan 2017
94.30%
Name

Avingtrans PLC

Chart & Performance

D1W1MN
XLON:AVG chart
P/E
3,388.51
P/S
90.83
EPS
0.11
Div Yield, %
0.01%
Shrs. gr., 5y
1.11%
Rev. gr., 5y
5.60%
Revenues
137m
+17.33%
24,329,00032,490,00040,026,00041,247,00037,559,00028,578,00036,260,00043,992,00045,280,00060,265,00022,557,00021,177,00022,714,00078,864,000104,044,00091,961,00098,516,00099,075,000116,437,000136,615,000
Net income
4m
-29.50%
1,301,0001,940,000159,0001,145,0001,128,000607,0001,261,000935,0001,300,0002,914,000-783,000420,000-296,000-4,486,0002,511,0001,386,0003,987,0006,478,0005,194,0003,662,000
CFO
1m
-86.21%
3,402,0001,816,0002,487,0001,160,000-386,0003,518,0002,637,0001,574,000-494,0001,550,0001,646,0007,791,000-3,260,000-6,892,0009,028,000-12,9996,446,0003,882,0009,677,0001,334,000
Dividend
Nov 07, 20242.9000000000000004 GBP/sh

Profile

Avingtrans plc manufactures and sells engineered components, systems, and services to the energy, medical, and infrastructure industries worldwide. It operates in three segments: Energy-EPM, Energy-PSRE, and Medical-MII. The company designs, manufactures, integrates, and services electric motors and pumps, steam turbines, gas compressors, pressure vessels, blast doors, containers, and skidded systems. It also designs and manufactures equipment for the medical, science and research communities, including products for medical diagnostic equipment; high performance pressure, vacuum vessels, and composite materials for research organizations; and superconducting magnets and helium-free cryogenic systems for use in magnetic resonance imaging and nuclear magnetic resonance. The company was incorporated in 1985 and is based in Chatteris, the United Kingdom.
URL
https://www.avingtrans.plc.uk/
IPO date
Dec 08, 2000
Employees
704
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑052016‑052015‑05
Income
Revenues
136,615
17.33%
116,437
17.52%
99,075
0.57%
Cost of revenue
130,979
110,350
93,536
Unusual Expense (Income)
NOPBT
5,636
6,087
5,539
NOPBT Margin
4.13%
5.23%
5.59%
Operating Taxes
1,180
1,246
971
Tax Rate
20.94%
20.47%
17.53%
NOPAT
4,456
4,841
4,568
Net income
3,662
-29.50%
5,194
-19.82%
6,478
62.48%
Dividends
(1,441)
(1,331)
(1,265)
Dividend yield
1.12%
0.98%
0.85%
Proceeds from repurchase of equity
563
589
(2,025)
BB yield
-0.44%
-0.44%
1.36%
Debt
Debt current
8,031
4,580
7,102
Long-term debt
25,981
3,997
4,090
Deferred revenue
368
1,342
Other long-term liabilities
328
3,328
3,097
Net debt
21,897
(18,690)
(18,674)
Cash flow
Cash from operating activities
1,334
9,677
3,882
CAPEX
(3,967)
(8,692)
(4,985)
Cash from investing activities
(13,577)
(12,633)
(9,523)
Cash from financing activities
6,780
(3,400)
(371)
FCF
(11,396)
5,429
(4,969)
Balance
Cash
12,115
17,717
24,287
Long term investments
9,550
5,579
Excess cash
5,284
21,445
24,912
Stockholders' equity
98,244
96,711
94,359
Invested Capital
132,015
94,652
92,498
ROIC
3.93%
5.17%
5.22%
ROCE
3.91%
5.10%
4.54%
EV
Common stock shares outstanding
33,361
33,007
33,134
Price
3.85
-6.10%
4.10
-8.89%
4.50
34.33%
Market cap
128,440
-5.09%
135,330
-9.24%
149,103
36.84%
EV
152,907
119,053
132,428
EBITDA
12,176
11,243
10,216
EV/EBITDA
12.56
10.59
12.96
Interest
1,175
570
367
Interest/NOPBT
20.85%
9.36%
6.63%